Trading Information (as per first day of trading)
- ISIN
- CH0012627250
- Symbol
- HBMN
- Security Number
- 1262725
- Sector
- Financial Services (incl. Real Estate) - 8700
- Regulatory Standard
- Standard for Investment Companies
- Index member
- SXI Life Sciences/SXI Bio+Medtech
Intermediaries
- Listing Agent
- UBS Investment Bank
- Auditor
- Ernst & Young Ltd.
- Lead Bank
- UBS Investment Bank
Information on the Issue
Security Details | |
---|---|
Class of Share | Action nominative |
Nominal Value | 60.00 CHF |
Total Shares outstanding (post issue; incl. Greenshoe - if any) | 11'262'859 |
Allocation Details | |
---|---|
Primary Shares | n/a |
Secondary Shares | n/a |
Primary Greenshoe | n/a |
Secondary Greenshoe | n/a |
Greenshoe Details | |
---|---|
Executed | no GS at all |
Ex-date | n/a |
Executed number of shares | n/a |
First Trading Day Details | |
---|---|
Price Range | n/a |
Issue Price | n/a |
First Open | 80.50 CHF |
First Close | 82.00 CHF |
Transaction size in Mio. (incl. executed Greenshoe) | n/a |
Market Capitalisation in Mio. (based on first closing price) | 924.00 CHF |